Margetuximab (Anti-ERBB2 / HER2 / CD340)
Margetuximab (Anti-ERBB2 / HER2 / CD340) is a Fc-domain optimized IgG monoclonal antibody directed against the human epidermal growth factor receptor 2 (HER2) with potential immunomodulating and antineoplastic activities. MW: 146.1 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2899 |
| Sku # | A2899-1mg*5 |
| Pricing | 1mg*5, $970.00 |